Applications of (S)-1-Benzyl-3-Hydroxypiperidine in Industrial Manufacturing

As a manufacturer specializing in the synthesis of advanced organic intermediates, we supply (S)-1-Benzyl-3-Hydroxypiperidine to support leading-edge processes across high-value, heavily regulated downstream industries. This raw material consistently meets strict quality standards required for pharmaceutical active ingredient building, crop protection agent formulation, and custom fine chemical synthesis. Below, we detail key industrial scenarios where our (S)-1-Benzyl-3-Hydroxypiperidine is dependably integrated, specifying real compliance norms, blending percentages, downstream technical application points, and the resulting finished product categories our clients produce.

1. Pharmaceutical Chiral Intermediate in CNS Drug Synthesis

Originating from our own GMP-compliant facilities, this material acts as a chiral intermediate in the production of central nervous system (CNS) drug substances—especially those in the piperidine-based antipsychotic and antidepressant classes. Formulators use precise enantiomerically pure lots to support regulatory filings and downstream API synthesis compliance. Drug manufacturers integrate the intermediate at key stages of multi-step syntheses, exploiting its stereochemistry to achieve desired pharmacological profiles in final APIs such as selective serotonin reuptake inhibitors or novel antipsychotic candidates.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP/NF and Ph.Eur. monograph standards (where applicable for intermediates)
• EMA Guideline on the specification limits for residues of metal catalysts or metal reagents
• FDA 21 CFR Part 211 (for facilities that integrate directly into API manufacturing)

Typical usage ratio

• 0.15–0.32 molar equivalent per mole of target API, depending on synthesis route and specific substitution patterns; process chemists adjust to minimize chiral byproduct formation

Downstream process integration

• Added during stepwise alkylation or amide coupling as a chiral nucleus generator; often enters after initial core scaffold assembly but before final API formation and purification

Final product types

• Active Pharmaceutical Ingredients (APIs) for CNS disorders, such as antipsychotics (aripiprazole analogs) and antidepressants
• Chiral API intermediates for further downstream derivatization

2. Building Block for Agrochemical Active Ingredients

Agrochemical manufacturers rely on the stereochemical integrity of this intermediate when producing piperidine-containing fungicides and herbicidal actives for regulated global markets. Producers incorporate it into mid-stage coupling reactions, enabling precise control over the final molecular architecture in crop protection actives. Quality assurance programs verify consistent chiral purity and chemical stability to comply with international residue and registration requirements.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• Regulation (EC) No 1107/2009 for EU crop protection product approval
• ISO 17025 accredited lab testing for residual solvents and impurities
• EPA 40 CFR Part 180 (Tolerances and exemptions for pesticide chemical residues in food)

Typical usage ratio

• 0.10–0.25 molar ratio on a per-batch basis, with adjustments depending on the complexity of the target active's molecular ring

Downstream process integration

• Introduced during asymmetric amination or functional group elaboration, forming the chiral core of the agrochemical active; typically used in the third or fourth synthetic step prior to final ring closure

Final product types

• Piperidine-based fungicidal actives (e.g., analogs in the phenylpiperidine family)
• Herbicidal actives containing chiral piperidine blocks

3. Intermediate in Custom Fine Chemical Synthesis for Contract Manufacturing

Contract development and manufacturing organizations (CDMOs) incorporate this material as an advanced intermediate during multi-step syntheses of specialty compounds. Its well-controlled stereochemistry allows custom synthesis of pilot-scale reference standards, analytical probes, and research chemicals that require precise chiral input. Industrial chemists value reliable batch consistency and documentation to facilitate rapid scalability and downstream quality review.

Industry compliance standards

• ISO 9001 Quality Management Systems
• REACH Registration, Evaluation, Authorisation and Restriction of Chemicals (EU)
• Responsible Care® Certification for safe chemical handling
• Material Safety Data Sheet (MSDS) and Certificate of Analysis (COA) verification

Typical usage ratio

• 0.08–0.18 molar equivalent per custom synthesis batch; ratio determined by specific end molecule requirements

Downstream process integration

• Integrated into fragment coupling, amide formation, or ring construction as the chiral piperidine fragment; typically enters in penultimate synthesis stages before target molecule completion

Final product types

• Reference standards for pharmaceutical and analytical use
• Chiral fine chemicals for specialty applications
• Bioactive research compounds

4. Precursor for Custom Synthesis of Analytical Reagents

Producers of enantiomerically enriched analytical reagents deploy this raw material in the development of affinity reagents, chemical derivatization kits, and chiral chromatography markers. The intermediate’s consistent chiral configuration supports the precise synthesis of reference markers used in method validation and process control by major QC laboratories and pharmaceutical manufacturers.

Industry compliance standards

• ISO/IEC 17025 for calibration and testing labs
• USP General Chapters <621> and <1225> for chromatographic system suitability and validation
• Good Laboratory Practice (GLP) compliance
• Supply documentation traceability per OECD requirements

Typical usage ratio

• 0.03–0.09 molar equivalent depending on the assay and reagent kit batch size; labs fine-tune quantity for desired resolution and detection sensitivity

Downstream process integration

• Entered as a building block in final coupling reactions for chiral marker synthesis, or in functionalization reactions during HPLC/GC standard production

Final product types

• Chiral HPLC/GC reference standards
• Derivatization agents for enantioselective analysis
• Chemical affinity reagents for quality control and R&D labs